Showing results (401-410 of 511) with videos related to
Sort By:
Pageof 52
Scientific Reports|December 8, 2023
Phenotyping EMT and MET cellular states in lung cancer patient liquid biopsies at a personalized level using mass cytometryLoukia G Karacosta, Danny Pancirer, Jordan S Preiss, et al.Immunopharmacology and Immunotoxicology|February 6, 2014
Immune correlates of talactoferrin alfa in biopsied tumor of relapsed/refractory metastatic non-small cell lung cancer patientsJonathan W Riess, Nupur Bhattacharya, Kim R M Blenman, et al.Brain Pathology (Zurich, Switzerland)|February 8, 2022
The association between neurodegeneration and local complement activation in the thalamus to progressive multiple sclerosis outcomeBenjamin J Cooze, Matthew Dickerson, Rukshikah Loganathan, et al.Journal of the National Cancer Institute|December 11, 2021
The Survival Impact of Second Primary Lung Cancer in Patients With Lung CancerEunji Choi, Sophia J Luo, Jacqueline V Aredo, et al.Clinical Lung Cancer|December 19, 2023
Efficacy of Mobocertinib and Amivantamab in Patients With Advanced Non-Small Cell Lung Cancer With EGFR Exon 20 Insertions Previously Treated With Platinum-Based Chemotherapy: An Indirect Treatment ComparisonSai-Hong Ignatius Ou, Thibaud Prawitz, Huamao M Lin, et al.Journal of Endourology|August 10, 2012
In-vitro assessment of a new portable ballistic lithotripter with percutaneous and ureteroscopic modelsAgnes J Wang, Gregory T Baldwin, James C Gabriel, et al.The Annals of Thoracic Surgery|October 18, 2024
The Society of Thoracic Surgeons Expert Consensus on the Multidisciplinary Management and Resectability of Locally Advanced Non-small Cell Lung CancerSamuel S Kim, David T Cooke, Biniam Kidane, et al.Journal of Immunology (Baltimore, Md. : 1950)|February 9, 2005
Decay-accelerating factor (CD55) is expressed by neurons in response to chronic but not acute autoimmune central nervous system inflammation associated with complement activationJohan van Beek, Marjan van Meurs, Bert A 't Hart, et al.Translational Lung Cancer Research|March 14, 2022
Risk factors for immune checkpoint inhibitor-related pneumonitis in non-small cell lung cancerYencheng Chao, Jiebai Zhou, Shujung Hsu, et al.Clinical Lung Cancer|December 8, 2023
Patient Selection and Outcomes for Hypofractionated Accelerated Radiation and Concurrent Chemotherapy for Non-Small-Cell Lung CancerCaressa Hui, Cesar Marquez, Brianna Lau, et al.Pageof 52